Familial Hypertrophic Cardiomyopathy (HCM) is frequently caused by mutations in the β-cardiac myosin heavy chain (β-MyHC). To identify changes in sarcomeric function triggered by such mutations, distinguishing mutation effects from other functional alterations of the myocardium is essential. We previously identified a direct effect of mutation R723G (cMyHC 723 ) on myosin function in slow Musculus soleus fibers. Here we investigate contractile features of left ventricular cardiomyocytes of HCM-patients with the same cMyHC 723 -mutation and compare to the soleus data.
Introduction
Familial hypertrophic cardiomyopathy (HCM) is the most frequent genetically transmitted cardiac disease with a prevalence of 1:500. 1 It is often characterized by asymmetric hypertrophy of left ventricular (LV) wall and septum and by an increased risk for sudden cardiac death particularly in young adults. 2 Myocyte disarray and interstitial fibrosis are hallmarks of HCM. Nearly all genotyped HCM cases revealed mutations in sarcomeric proteins. Yet, the underlying functional changes at the cardiomyocyte level possibly initiating disease development are still largely unknown.
To investigate mechanisms triggering HCM pathogenesis we focused on mutations in the β-cardiac myosin heavy chain (β-MyHC) gene (MYH7). MYH7 mutations are responsible for approximately 30-40% of all genotyped HCM cases. 3 The β-MyHC isoform is expressed in ventricular myocardium and in slow-twitch skeletal muscle fibers. [4] [5] [6] We have previously studied functional effects of different β-MyHC-missense mutations in slow-twitch fibers of M. soleus. Data on functional effects of HCM-related β-MyHC-mutations in human ventricular cardiomyocytes are, however, scarce. [7] [8] [9] [10] A unique opportunity arose for a direct comparison of effects on myocardium vs. slow twitch skeletal muscle when two severely affected HCM patients carrying β-MyHCmutation R723G (cMyHC 723 ) 11 underwent heart transplantation and their LV myocardium became available. The LV of both HCM-patients with cMyHC 723 was functionally equivalent to that of end-stage heart failure (HF). We had previously characterized the cMyHC 723 effects in M. soleus fibers from one of these patients. 12, 13 Analysis showed that the direct functional effect of the mutation, which is located in the converter domain of the myosin head, is to cause reduced Ca
2+
-sensitivity in M. soleus fibers and a 20% increase in maximal force generation. The force increase was found to be due to increased force generation by the individual mutated myosin heads because of increased molecular stiffness. There was no evidence of adaptational processes in the M. soleus fibers with cMyHC 723 .
Having now both M. soleus and myocardial tissue, in one case even from the same individual, we asked whether the effects of mutation cMyHC 723 on contractile function are the same in cardiomyocytes and slow fibers of M. soleus. In addition, this required us to clarify also whether cardiomyocyte function is affected by other alterations of myocardial contractility such as changes in protein phosphorylation. From studies on human cardiac tissue it is known that end-stage HF is characterized by desensitization of the β-adrenergic pathway resulting in e.g., dephosphorylation of cardiac troponin I (cTnI) 14 , Myosin binding protein C (cMyBP-C) 15 , and titin. 16 To assess morphological features which might affect function such as myocyte and myofibrillar organization, we also performed structural studies by light-and electron microscopy of ventricular tissue from patients and donors.
Methods

Patients and cardiac biopsies
Myocardial tissue was obtained upon cardiac transplant from the LV of a male patient (H27), age 55 years, from family 26, II-5, and a female patient (H29), age 53 years, from family 11, III-8, see Enjuto et al. 11 Genotyping and clinical details of the patients were published previously 11, 17 , information about their medication and clinical status at the time of heart transplant are given in Supplementary Table 1 . M. soleus tissue was obtained from patient H27 one year before heart transplantation (HT). 12 Both patients are heterozygous for β-MyHC-mutation R723G and had initially developed the classical clinical phenotype of HCM with diastolic dysfunction, hypertrophy of the LV wall and interventricular septum, ST-T wave abnormalities, pathological Q-wave (patient H29) and heart blocks, similar to other related and unrelated carriers with mutation R723G. The patient's hypertrophic cardiomyopathy eventually progressed into LV dilatation and end-stage systolic heart failure (NYHA III-IV). 11, 17 Development of heart failure is found in a subgroup of HCM patients.
2
Control tissue was obtained from non-transplanted donor hearts (N=5, 23-52 years of age, mean age 39±6 years; 2 female, 3 male) for which no suitable recipient was found. Our previous studies showed no age-dependent differences in any of the parameters of sarcomere function in control cardiomyocytes. 18 After dissection, all cardiac samples were immediately frozen and stored in liquid nitrogen. For mechanical preparation of single myocytes 19 or for gel-electrophoretic protein analysis, small pieces of the tissue were generated by slightly crushing the larger biopsies with a mortar and pestle permanently cooled by liquid nitrogen. M. soleus biopsies of approximately 10 mm x 10 mm x 15 mm were excised under local anaesthesia as described previously. 12 A few pieces of muscle tissue were frozen directly in liquid nitrogen for later mRNA-analysis. From the remainder of the biopsies small fiber bundles were dissected and treated as published. 12, 20 Approval of the local ethics committees and written informed consent for use of the tissue was obtained.
Force and rate constant of force redevelopment (k tr ) measurements in single cardiomyocytes
As described previously 19, 21 , small cardiac tissue samples were defrosted in relaxing solution (in mmol/L: free Mg, 1; KCl, 145; EGTA, 2; MgATP, 4; imidazole, 10; pH7.0), mechanically disrupted and incubated for 5 minutes in relaxing solution supplemented with 0.5% Triton X-100 to remove all membrane structures. Subsequently, cells were washed twice in relaxing solution, after which single cardiomyocytes were attached with silicone adhesive between a motor and a force transducer ( Figure 1A ). Sarcomere length of isolated cardiomyocytes was adjusted to 2.2 µm. The pCa (-10 log[Ca 2+ ]) ranged from 9.0 (relaxation solution) to 4.5 (maximal activation). All force values were normalized for cardiomyocyte cross-sectional area. Exposure to a series of solutions with intermediate pCa values (pCa 6.0-5.0) yielded the baseline force-pCa relation. On transfer of the cardiomyocyte from relaxing to activating solution, isometric force started to develop ( Figure 1B) . Once a steady state force level was reached, the cell was shortened within 1 ms to 80% of its original length (quick release protocol) to determine the baseline of the force transducer. The distance between the baseline and the steady force level is the total force (F total ). After 20 ms, the cell was restretched to isometric length, which was followed by a rise in force back to isometric level. After returning the cell to the relaxing solution, a slack test of 10 s duration was performed to determine passive force (F passive ). Maximal force was calculated according to F max =F total -F passive . K tr , the rate constant of force redevelopment, was measured during isometric contraction after a short period of unloaded isotonic shortening of the cardiomyocytes 22 .
Force measurements were repeated after incubation of cells with 100U/mL of the catalytic subunit of protein kinase A (PKA, Sigma) for 40 min or with 0.5U/mL protein phosphatase-1 (PP-1, Upstate Biotechnology) for 60 min, both at 20°C, i.e. after adjusting phosphorylation levels between donor and cMyHC 723 cardiomyocytes
β-MyHC mRNA quantification
Relative abundance of mutated vs. wild-type MYH7-mRNA was determined by a specific restriction digest approach and by real-time PCR (RT-qPCR) as described recently. 23 For reverse transcription after isolation of total RNA from flash frozen muscle tissue a MYH7-specific primer was used. Mutation specific primers were used for amplification of a fragment containing the mutation. To obtain one cleavage site specific for the wildtype sequence, a mutagenic forward primer was used for PCR. For quantification, the PCR product of 281 base pairs (bp) was digested with the restriction enzyme NdeII (Promega). This yielded 35bp, 90bp and 156bp fragments for the wild-type and 125bp and 156bp fragments for the mutated PCR product. The restriction fragments were separated on 3.5% ethidium-bromide-agarose gels. The fraction of mutated transcript was determined from the integrated intensity/bp ratio of the mutation-specific 125 bp fragment vs. the 156 bp fragment within the linear range of detection.
To further validate the findings (Supplementary Table 2 ) with an independent method, we also used an allele-specific real-time PCR assay using an ABI Prism 7000 platform. cDNA was synthesized as described and subjected to amplification using primer and hybridization probes (labelled at the 5' ends with VIC and 6-FAM for wild-type or mutant alleles, respectively) specific for the MYH7 R723G mutation (Applied Biosystems). This allowed detection of the two alleles in a single-tube analysis. Relative quantification occurred according to the delta-C T method. 24 Both methods yielded essentially the same results.
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Myofilament protein phosphorylation
Protein phosphorylation was determined as previously described. 25 To preserve the endogenous phosphorylation status, frozen biopsies were homogenized in liquid nitrogen and re-suspended in 1ml cold 10% trichloroacetic acid solution (TCA; dissolved in acetone containing 0.1% (w/v) dithiothreitol (DTT)). TCA-treated tissue pellets were homogenized in sample buffer containing 15% glycerol, 62.5mM Tris (pH 6.8), 1% (w/v) SDS and 2% (w/v) DTT. Tissue samples were separated on gradient gels (Criterion tris-HCl 4-15% gel, BioRad) and proteins were stained for one hour with Pro-Q Diamond Phosphoprotein Stain. Fixation, washing and de-staining were performed according to the manufacturer's guidelines (Life Technologies, Darmstadt, Germany). To assess protein content, subsequently gels were stained overnight with SYPRO Ruby stain (Life Technologies, Darmstadt, Germany). Phosphorylation status of myofilament proteins was expressed relative to protein expression of cMyBP-C to correct for differences in sample loading. Staining was visualized using the LAS-3000 Image Reader and signals were analyzed with AIDA. For two-dimensional gel electrophoresis samples were loaded on immobiline strips with a pH gradient of 4.5 to 5.5 (GE Healthcare, Uppsala, Sweden) as described before 25 . In the second dimension proteins were separated by SDS-PAGE using an acrylamide to bisacrylamide ratio of 200:1 in the separating gel (12% total acrylamide, pH 9.3) and of 20:1 in the stacking gel (3.5% total acrylamide, pH 6.8). Gels were stained with Coomassie blue (BioSafe Coomassie G-250; BioRad), scanned and analyzed using Image Quant (Molecular Dynamics). For identification of apolipoprotein A-1 in hitherto unknown spots on the gels tandem mass spectrometry was used as described previously. 26 Western immunoblot to determine cTnI phosphorylation was carried out using an antibodies specific for non-phosphorylated cTnI-PKA sites (serines 23 and 24) and for total cTnI, respectively, as described previously. 27 For myosin heavy chain isoform analysis, samples were loaded on SDS polyacrylamide gels with 5% polyacrylamide in stacking gel and 8.8% polyacrylamide and 5% glycerol in separation gel. For electrophoresis a cooled chamber at 4°C (C.B.S. Scientific) in a refrigerator with 21 cm long glass plates was used. A constant voltage of 230V was applied for minimal 30 hours. The gels were then silver stained and densitometrically analyzed with Totallab TL100.
Light-and electron microscopy
Tissue preparation for histology and electron microscopy occurred as described previously. 18, 28 For histological analysis 4 µm thick sections were prepared from formalin (5%) fixed and paraffin-embedded cardiac tissue. After Elastica van Gieson-staining, images of the sections were obtained with an inverted microscope (x100). For electron microscopy, myocardial biopsies were fixed in 2% (v/v) glutaraldehyde for 30 min and in 1.5% (w/v) osmium tetroxide for 10 min, dehydrated with acetone and embedded in Epon812. Ultrathin sections were collected on 300-mesh Formavar-coated nickel grids and contrasted with uranyl acetate for examination on a Jeol-1200EX electron microscope. Myofibrillar density was calculated from the sum of myofibrillar area over the total cell area in 5 representative cardiomyocytes per tissue sample (total of at least 35 cells).
Data analysis
Force-pCa relations were fit to a modified Hill-equation. 19 Results are given as mean±SEM.
Differences between donor and cMyHC 723 -cardiomyocyte groups were examined by a twosample unpaired Student t-test with P-values <0.05 considered as statistically significant. Effects of PKA in donor and cMyHC 723 samples, respectively, were tested by one-way ANOVA and Tukey's mean value comparison. A P-value <0.05 was considered significant for ANOVA.
Results
Unexpected low force generation and unchanged Ca
2+ -sensitivity in cMyHC 723 cardiomyocytes
For functional characterization of HCM mutation R723G in cardiac tissue, we investigated isometric force and Ca ] (e.g., Figure 1D ), the variance is much smaller, and the shift in the force-pCarelationship by the cMyHC 723 -mutation in M. soleus fibers is more obvious (cf. Figure 5B in 12 ). 
Equally high expression level of mutant β-MyHC at mRNA and protein level in both ventricular myocardium and M. soleus
The different effects of cMyHC 723 in cardiomyocytes and M. soleus could be due to different levels of cMyHC 723 expression in the HCM myocardium compared to M. soleus fibers. Using both a restriction digest analysis and real-time PCR as recently described 23 , the relative abundance of mutated vs. wild-type β-MyHC-mRNA was quantified. In cardiac tissue with cMyHC 723 the fraction of mutated β-MyHC-mRNA was on average 69% for patient H27 in different regions of the LV wall and 67% for patient H29 (Supplementary Table 2 ). In M. soleus of patient H27 and two other patients we previously found a fraction of 66±7% mutated β-MyHC-mRNA. At the protein level, the fraction of mutated β-myosin incorporated into the sarcomeres of M. soleus fibers was 62±6% for patient H27 and his brother. 6 In myocardium, preliminary protein quantification yielded very similar 63±11% of mutated protein. 23 Thus, the extent of expression/incorporation of mutant myosin in the contractile apparatus does not explain the discrepant functional effects between M. soleus and myocardium.
Myocardium-specific reduction in phosphorylation of sarcomeric proteins, which could account for functional differences compared to M. soleus
To test for possible modifiers of contractile properties in myocardium 18, 19, 29 , the phosphorylation status of sarcomeric proteins was determined. Proteins were separated by 1-dimensional gel electrophoresis and stained with phospho-specific stain ProQ Diamond ( Figure 2A ) and protein stain SYPRO Ruby ( Figure 2B ). Phosphorylation of cMyBP-C, cTnI and myosin light chain 2 (MLC-2) was significantly reduced (P<0.001) in cMyHC 723 compared to donor myocardium ( Figure 2C ). On average, cMyBP-C and MLC-2 phosphorylation were both reduced to 42% and cTnI phosphorylation to 11% in cMyHC 723 tissue compared to donor tissue. Phosphorylation of cardiac troponin T (cTnT) was significantly reduced only in LV tissue from cMyHC 723 patient H29. The substantial dephosphorylation of cTnI in cMyHC 723 myocardium was confirmed by Western immunoblot using an antibody specific for nonphosphorylated cTnI-PKA sites (serines 23 and 24). The ratio of dephosphorylated cTnI relative to Ponceau-stained actin in cMyHC 723 myocardium was on average 1.66±0.3 (n=3 samples), while in donor tissue no dephosphorylated cTnI was detected. Isoform composition and phosphorylation status of ventricular myosin light chains and cTnT in the myocardial samples was assessed using 2D-PAGE. 25 In LV-myocardium of cMyHC 723 both MLC-2 isoforms (MLC-2 and MLC-2*) are dephosphorylated ( Figure 3B ) compared to donor tissue ( Figure 3A) . However, only the decrease of the phosphorylated MLC-2P and the increase of the unphosphorylated MLC-2* were significant ( Table 1 ). The percentage of phosphorylated MLC-1 did not differ between donor and cMyHC 723 myocardium. On average, cTnT phosphorylation was reduced by 15% in cMyHC 723 tissue compared to donor, while ProQ stained 1D-gels revealed a somewhat larger reduction in cTnT-P of 34%. This is only seen in tissue from patient H29 ( Figure 2C ), while for patient H27 cTnT phosphorylation was well preserved ( Figure 3B ). An additional difference between cMyHC 723 and donor ventricular tissue was found for pro-apolipoprotein A-1 (GenBank number AAA51747.1). Pro-apolipoprotein A-1 is a precursor of apolipoprotein A-1, which is involved in lipid transport and metabolism and is a major protein of plasma HDL (high density lipoprotein). Gel-analysis of different parts of the LV of H27 ( Figure 3B ) revealed more than five times higher pro-apolipoprotein in septum (pro-apo/actin ratio=34.6) compared to tissue of two different regions of the free LV wall (pro-apo/actin ratio=6.3±3) and to donor tissue (Pro-Apo/actin ratio=2.7).
To see whether cMyHC isoform composition contributes to the different mutation effects in cardiomyocytes and slow M. soleus fibers, we analyzed the isoforms in the cMyHC 723 ventricular samples using 1D-gel electrophoresis. No significant amounts of β-MyHC could be detected in the samples of the patients (Supplementary Figure 1) . Thus, it is unlikely that isoform composition is responsible for the observed functional differences. H27; B) . IEF, isoelectric focusing; TnT and TnT-P, unphosphorylated and monophosphorylated cardiac troponin T; MLC-1, ventricular myosin light chain 1; MLC-2 and MLC-2*, two isoforms of ventricular myosin light chain 2, both partly phosphorylated (MLC-2P and MLC-2*P, respectively). In septum of cMyHC 723 -patient H27 a quite prominent spot is seen, identified by mass spectrometry as proapolipoprotein A-1 (Pro-ApoA-1).
Reduced Ca
2+
-sensitivity in cMyHC 723 myocytes after phosphorylation with PKA We next examined the influence of the significantly reduced (PKA-dependent) phosphorylation of cTnI and cMyBP-C in cMyHC 723 myocardium on Ca 2+ -sensitivity. As described above, the Ca 2+ -sensitivity in cMyHC 723 cardiomyocytes did not differ from donor myocytes. When we, however, repeated measurements of force-pCa relations after PKAtreatment to match phosphorylation levels, the resulting reduction in pCa 50 was much larger in cMyHC 723 (ΔpCa 50 =0.16±0.01, n=50 cells) than in donor cardiomyocytes (ΔpCa 50 =0.04±0.01, n=9 cells; P<0.001, Table 2 ). Thus, PKA treatment of donor and cMyHC 723 cardiomyocytes uncovered a significant difference in the force-pCa relationships between cMyHC 723 (pCa 50 =5.40±0.01) and donor (pCa 50 =5.51±0.02) cells once phosphorylation was maximized for both tissues ( Figure 4A&B ). The steepness of the force-pCa relation (Hill coefficient, nH) was very similar for donor and cMyHC 723 cardiomyocytes and not significantly affected by PKA-treatment ( Table 2 ). The reduced Ca 2+ -sensitivity in cMyHC 723 -cardiomyocytes upon PKA-treatment compared to donor is comparable to the reduced Ca 2+ -sensitivity in M. soleus fibers with cMyHC 723 (0.14 pCa units). 12 To find out whether the reduced Ca 2+ -sensitivity is due to changes in cross-bridge cycling kinetics we recorded the rate constant of force redevelopment (k tr ) after PKA-treatment. Figure 4E shows that k tr at different [Ca 2+ ] is essentially the same for donor and cMyHC 723 myocytes. For M. soleus fibers of controls and cMyHC 723 also no difference in the k tr -pCa relationship was found (data not shown). Nevertheless, the mutation could still cause changes in parameters of cross-bridge cycling kinetics (f app and g app ) which do not significantly affect the overall rate constant k tr (see discussion for details).
To test whether the reduced MLC-2 phosphorylation in cMyHC 723 cardiomyocytes might also affect their Ca 2+ -sensitivity, we incubated cMyHC 723 and donor cardiomyocytes with protein phosphatase PP-1 29 and subsequently measured force-pCa relations before and after additional PKA-treatment. PP-1 adjusts all myocytes to a similarly low phosphorylation level particularly of MLC-2. 25, 29 No significant difference of pCa 50 was observed after treatment with PP-1 ( Figure 4F ). Subsequent PKA incubation reduced pCa 50 to a similar extent as seen without PP-1-pretreatment ( Figure 4A ). Phospho-gel analysis of tissue samples after PP-1 and subsequent PKA treatment on average showed similar phosphorylation levels of cMyBP-C, cTnI and MLC-2 for donor and cMyHC 723 hearts (Supplementary Figure 2) . This indicates that the significant reduction of pCa 50 seen in cMyHC 723 myocytes compared to donor after PP-1 -PKA treatment ( Figure 4F ) most likely is not due to different phosphorylation levels of these proteins in donor and cMyHC 723 cardiomyocytes. In studies on M. soleus fibers, which also showed reduced pCa 50 with cMyHC 723 , all fibers were pre-treated with PP-1 to exclude effects of different phosphorylation of slow MLC-2 (for details see 12 ). 
Lower active and passive forces related to structural deficiencies
The lower F max of cMyHC 723 myocytes compared to donor myocytes was not restored by phosphorylation of PKA sites and dephosphorylation of PP-1 sites ( Figure 4D ). As a possible reason for the reduction in F max , we looked at changes in morphology of the ventricular tissue at the cellular and subcellular level. Light microscopy ( Figure 5A ) of myocardial tissue of both cMyHC 723 patients demonstrated extensive areas with intercellular connective tissue, which was similar in the LV wall of both patients. In the septum of patient H27, it was even more pronounced. This was not seen in donor myocardium. Probably most relevant for the reduced force generation of individual cardiomyocytes are massive changes in sarcomeric ultrastructure of cMyHC 723 compared to donor cardiomyocytes. Electron microscopy revealed not only Z-disc irregularities but also pronounced disarray ( Figure 5B ) and reduction in density of myofibrils by 26% in cMyHC 723 cardiomyocytes compared to donor ( Figure 5C ). Importantly, in cMyHC 723 cardiomyocytes the observed disarray, i.e., the deviation of the myofibril orientation from a common axis (double arrows in Figure 5B , bottom panel) indicates a deviation from a common force vector.
In addition, changes in cross-bridge turnover kinetics could contribute to reduced F max in cMyHC 723 even though the rate constant of force redevelopment (k tr ) at saturating [Ca 2+ ], k tr(max) , was very similar in cMyHC 723 and donor cardiomyocytes and remained unchanged by PKA-treatment in both groups (Table 2; Figure 4E ). Changes in cross-bridge kinetics, which do not affect k tr could still contribute to the reduced force generation of the cMyHC 723 cardiomyocytes (see discussion for more details).
Besides reduced F max , also F passive was lower in cMyHC 723 cardiomyocytes compared to donor. The difference was 1.25 kN/m 2 ( Figure 4C ; Table 2 ) and increased upon PKA incubation to 1.81 kN/m 2 , mainly due to a decrease in F passive for the cMyHC 723
cardiomyocytes. Force at maximal Ca
2+
-activation (pCa 4.5) was essentially unaffected by PKA-treatment both in cMyHC 723 and donor, i.e. the difference in F max remained unchanged ( Figure 4D ; Table 2 ). 
Discussion
Changes in contractile function of myocardium triggered by HCM-mutations can be direct effects of such mutations on sarcomeric functions, effects of additional changes like modified protein phosphorylation, or the result of morphological alterations. In the present study, we attempted to discern contributions of these different factors on contractile function of cardiomyocytes with myosin mutation R723G. We (i) analyzed contractile function of cMyHC 723 -cardiomyocytes before and after matching protein phosphorylation of donor and cMyHC 723 -cardiomyocytes and (ii) analyzed myofibrillar density and organization via EM. Finally, we compared data of cMyHC 723 -cardiomyocytes and previous data from M. soleus fibers with the same mutation.
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Reduced Ca
2+ -sensitivity becomes detectable by PKA-treatment
Unexpectedly, the cMyHC 723 cardiomyocytes isolated from tissue samples of affected patients showed the same Ca 2+ -sensitivity as donor cardiomyocytes. Phosphorylation of cTnI, however, was much lower in both patients' hearts compared to donor myocardium, which is expected to shift the force-pCa relation to higher Ca 2+ -sensitivity. 19 Matching phosphorylation levels of donor-and cMyHC 723 -cardiomyocytes by phosphorylation of PKAdependent sites and dephosphorylation of PP-1 sites resulted in reduced Ca
2+
-sensitivity of cMyHC 723 -cardiomyocytes, which was comparable to the reduced Ca 2+ -sensitivity found earlier in M. soleus fibers with the same R723G mutation. 12 Such lower Ca
-sensitivity is at odds with the idea that HCM-mutations are associated with increased Ca 2+ +-sensitivity, while in DCM reduced Ca 2+ -sensitivity predominates. 30, 31 The reason for reduced cTnIphosphorylation in cMyHC 723 -cardiomyocytes is not clear. It could be due to the end-stage HF of the patients since earlier studies on idiopathic dilated and ischemic failing myocardium without sarcomeric mutations showed similarly reduced cTnI-phosphorylation. 14, 18, 19 The reduced cTnI-phosphorylation, however, might also reflect a hypertrophic cardiomyopathytypical posttranslational modification as it was also observed in non-failing myectomy tissue from patients with hypertrophic obstructive cardiomyopathy.
9,32
The reduction in Ca
2+
-sensitivity when phosphorylation levels are matched is most likely caused by changes in cross-bridge cycling kinetics. It has been shown that Ca 2+ -sensitivity depends on the ratio of the rate constants of cross-bridge cycling, f app /g app . This ratio can modulate contractile function independent of the regulatory protein complex on actin. 33 Isometric force (F) is determined by 33 ,
i.e. by the transition of the cross-bridges into force-generating states (f app ) and their return to non-force-generating states (g app ), by F*, the mean force generated by each myosin head, and by n, the total number of actively cycling myosin heads which can bind to actin within a half sarcomere (depending e.g., on filament overlap). Possible changes in F* (as found for cMyHC 723 globular heads, 13 ) and n are expected to affect force generation at each [Ca 2+ ] similarly, therefore changes in these parameters cancel out in normalized force-pCa relationships. It has been shown that an increase in g app and/or a decrease in f app , i.e., any decrease in f app /g app causes reduced force generation with a shift in the force-pCa relationship to the right, i.e., reduced Ca 2+ -sensitivity. ]. This, however, does not preclude reciprocal changes in the two rate constants that reduce f app /g app but leave f app + g app essentially unchanged. Such reciprocal changes could cause a suppression of maximal force and a decrease in Ca 2+ -sensitivity. We calculated possible changes of f app and g app based on the measured values for k tr and for F max at full and half-maximal activation. As value for g app we took 0.17 sec -1 from data on heart myofibrils at 15°C (c.f. 10 ]; slow k rel corresponds to g app ).
The reduced normalized force of cMyHC 723 cardiomyocytes seen after PKA treatment at halfmaximal activation ( Figure 4B ) can be accounted for within experimental error by an approximately 28% increase in g app and an approximately 40% decrease in f app compared to donor myocytes. The increased unloaded shortening velocity observed in the M. soleus fibers also suggests a faster g app for the cMyHC 723 myosin. In summary, reduced Ca
-sensitivity is most likely the result of changes in cycling kinetics of cMyHC 723 caused by the mutation. F max is also affected by the force contribution of the individual molecule (F*) which is enhanced for this mutation due to increased resistance to elastic distortion. 13 Thus, increased force contribution per myosin molecule and reduced Ca 2+ -sensitivity are not contradictory.
Reduced maximal active and passive forces
The reduced F max in cMyHC 723 cardiomyocytes by 31% is in strong contrast to 20% increase in F max of soleus fibers with this mutation. 13 For patient H27 the skeletal biopsy was taken only one year before the heart transplantation, this short time difference is unlikely to be responsible for such drastic force reduction. Reduced F max is in contrast to most findings in non-HCM-related heart failure where F max is often unchanged. 34 However, in cardiomyocytes isolated from myectomy tissue of hypertrophic cardiomyopathy patients with LV outflow tract obstruction F max was also reduced. 9, 32 Similar expression levels of mutated β-MyHCmRNA and protein in myocardium and M. soleus 23 showed that the discrepancy is not due to altered expression of mutated myosin. In addition, studies using X-ray diffraction and confocal microscopy indicated that myosin-converter-domain mutations like R723G, R719W or G741R, do not alter sarcomeric composition and ordered assembly of myofilaments in Triton-permeabilized M. soleus fibers 35 , own unpublished observations. In general, assembly and formation of the thick filaments is normal with other myosin head-domain mutations. 36 Most likely, a substantial part of the reduced F max in cMyHC 723 cardiomyocytes is due to the significantly lower density and the disarray of myofibrils observed by electron microscopy. We estimated F max of the cMyHC 723 cardiomyocytes expected if myofibrillar density were not lowered by 26%. In this case, F max would be increased from 24.2 kN/m 2 ( 4 Yet, the MLC-1 is in very close proximity to the converter region of the cMyHC head domain where the mutation is located. Therefore, changes in possible interactions between myosin heavy chain and MLC-1 could influence the effect of cMyHC 723 on stiffness and force of the individual mutated cMyHC heads 13 and thus affect F max differently in M. soleus and cardiomyocytes. F passive of myocytes mainly depends on the elastic properties of titin, which spans each half sarcomere from the Z-disc to the M-line, anchoring the myosin filaments. Therefore, the loss and distortion of myofibrils may also explain the 28% lower F passive of cMyHC 723 cardiomyocytes. This is actually different from heart failure 29 and from cardiomyocytes isolated from myectomy tissue of patients with hypertrophic cardiomyopathy 9,32 where F passive was unchanged. The additional reduction of F passive by rephosphorylation with PKA could well be a direct consequence of titin phosphorylation 38 , indicating dephosphorylated titin in the failing HCM myocardium. For the patient's myocardial function and particularly for impaired diastolic filling, however, the massive interstitial fibrosis of the left ventricular wall and of the septum seen in histology is probably the major disadvantage, despite the reduced F passive of the isolated cardiomyocytes.
The course of HCM development
With a study on cardiac samples from HCM patients at end-stage heart failure it is essentially not possible to assess initial effects and early stages of the development of HCM phenotype features. However, based on functional studies on M. soleus fibers with the same mutation 12, 13 and on analysis of expression levels of mutated myosin in myocardium and M.
soleus of the heterozygous patients 23 , we may develop the following hypothesis: We assume that the mutation effects observed in M. soleus fibers, where no myofibrillar deficiencies and phosphorylation changes were obvious, reflect the situation in cardiomyocytes of the patients at the very beginning of the disease. In this case, in cMyHC 723 cardiomyocytes at early stages of disease only a slight change of average force generation at submaximal calcium-concentrations would be detectable ( Figure 1F ) and major adaptations and myofibrillar deficiencies may still be absent. We hypothesize that subsequently disarray develops in myocardium because of variable expression of mutated and wild-type myosin in individual myocytes, resulting in functional variability among individual cells. 12, 23 This is based on studies on cMyHC 723 muscle fibers where we found, different from control fibers, large variability in Ca
2+
-sensitivity and force generation among individual cMyHC 723 -fibers ranging from near normal values to highly significant deviations from control. 12 If in myocardium similar variability exists among neighboring cardiomyocytes at early stages of the disease, imbalances in force generation among cardiomyocytes and myofibrils will trigger non-uniform contraction of myocardial tissue, i.e., over contraction vs. over stretch of individual myocytes. Due to the arrangement of cardiomyocytes in a network with cells in series and branched cells, in the long run nonuniform contraction results in cellular and myofibrillar disarray. In M. soleus, due to the unbranched, parallel arrangement of fibers, no such disarray is expected to develop. In myocardium, disarray with structural damage or even loss of myocytes under increased strain will cause impaired force output, presumably triggering hypertrophy for compensation. Alterations of contractile function of cardiomyocytes such as reduced cTnIphosphorylation always affect both mutated and wild-type actin-myosin-complexes in the same way, and therefore cannot compensate for the imbalances in force generation. To test unequal cMyHC 723 expression which is the basis of this hypothesis requires downscaling of β-MyHC-mRNA quantification to the level of individual cardiomyocytes.
In conclusion, the observed functional differences between M. soleus fibers and cardiomyocytes with mutation cMyHC 723 can be explained by alterations of protein phosphorylation and morphology of cMyHC 723 cardiomyocytes. These alterations could be due to HF in these patients but might also reflect HCM-phenotype-related post-translational modifications, as these were observed in myectomy tissue from patients with hypertrophic obstructive cardiomyopathy without HF. 9, 32 Thus, in the case of cMyHC mutations in HCM, M. soleus biopsies appear useful for functional studies trying to identify direct effects of HCM mutations and to suggest strategies for early prevention of typical HCM features in young mutation carriers. Yet, long-term studies on contractility and ultrastructure of the myocardium of genotyped family members beginning at very young age and studies on animal models with near human physiology are needed to more completely understand human HCM pathogenesis.
Supplementary Material Supplementary Tables
Supplementary Table 1 TnT-phosphorylation was significantly reduced only in LV tissue from patient H29 (cf. Figure 2) . Supplementary Figure 1. A. 1D-gel showing cMyHC isoform composition of different LV myocardium samples of the cMyHC 723 patients H27 and H29 and of a donor myocardium sample. As reference for -cMyHC, atrial samples of H27 and H29 were also run on the gel. B. and C. show densitometric analyses of silver stained bands in A.. The intensity profiles were aligned with respect to the MyHC which is at a higher distance on the gel. The examined left ventricular samples did not show detectable amounts of -MyHC. Figure 2. A. ProQ Diamond stained gels from donor (lane 1) and cMyHC 723 heart (lane 2) to illustrate that PP-1 and subsequent PKA treatment resulted in a similar phosphorylation pattern in donor and HCM tissue. B. Analysis of PP-1 -PKA treated samples showed on average a similar phosphorylation of cMyBP-C, cTnI and MLC-2 in cMyHC 723 myocardium compared to PP-1 -PKA treated donor myocardium, in which values were set to 1.
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